Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 4/20 | 0.77 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.59 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.59 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.59 |
| ▸ | NQO2 | P16083 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | LDHA | P00338 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | MPI | P34949 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30182714 | 1.00 | CDC25B (0.77) | CDC25BNR4A1NR4A2NR4A3NQO2 | |
| Hydrochloric Acid SCHEMBL3914059 | 0.98 | CDC25B (0.75) | CDC25BNR4A1NR4A2NR4A3NQO2 | |
| Ammonia Solution, Strong SCHEMBL9297218 | 0.98 | CDC25B (0.75) | CDC25BNR4A1NR4A2NR4A3NQO2 | |
| SCHEMBL10884687 | 0.87 | CDC25B (0.61) | CDC25BNR4A1NR4A2NR4A3NQO2 | |
| SCHEMBL1825309 | 0.85 | CDC25B (0.58) | CDC25BNR4A1NR4A2NR4A3NQO2 | |
| SCHEMBL11057958 | 0.83 | CDC25B (0.71) | CDC25BNQO2POLBGPR35MEN1 | |
| SCHEMBL8797558 | 0.82 | CDC25B (0.60) | CDC25BNR4A1NR4A2NR4A3NQO2 | |
| SCHEMBL10909445 | 0.82 | CDC25B (0.60) | CDC25BNR4A1NR4A2NR4A3NQO2 | |
| SCHEMBL3914053 | 0.82 | CDC25B (0.60) | CDC25BNR4A1NR4A2NR4A3NQO2 | |
| SCHEMBL31533158 | 0.82 | NR4A1 (0.61) | CDC25BNR4A1NR4A2NR4A3POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1399 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302824-A1 | IN SITU READY-TO-USE INJECTION FORMULATIONS OF POSACONAZOLE FREE OF CYCLODEXTRIN AND ITS DERIVATIVES | Hefei Cosource Pharmaceuticals Co., Ltd (CN) | 2025-10-02 | — | — | US | claimed |
| EP-3990570-B1 | POLYMER FLAME RETARDANT AND METHOD FOR ITS MANUFACTURE | KLINGELBERG PRODUCTS AS (NO) | 2025-06-11 | — | — | EP | claimed |
| US-20250170094-A1 | ANTI-INFLUENZA VIRUS PHARMACEUTICAL FORMULATIONS | Hefei Cosource Pharmaceuticals Co., Ltd (CN) | 2025-05-29 | — | — | US | claimed |
| CN-120037179-A | Anti-influenza virus pharmaceutical preparation | 合肥合源药业有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-116943622-A | Preparation method of molecularly imprinted activated carbon for targeted degradation of naphthalene | 同济大学 | 2023-10-27 | — | — | CN | claimed |
| US-20220267546-A1 | Polymer Flame Retardant and Method for Its Manufacture | KLINGELBERG PRODUCTS AS (NO) | 2022-08-25 | — | — | US | claimed |
| WO-2022139593-A1 | AMIDINES AND SOLVENT FREE METHOD FOR THEIR MANUFACTURE | KLINGELBERG PRODUCTS AS (NO) | 2022-06-30 | — | — | WO | claimed |
| EP-3990570-A1 | POLYMER FLAME RETARDANT AND METHOD FOR ITS MANUFACTURE | Klingelberg Products AS (NO) | 2022-05-04 | — | — | EP | claimed |
| CN-114206991-A | Polymer flame retardant and method for producing same | 克林格贝格产品公司 | 2022-03-18 | — | — | CN | claimed |
| CN-108624143-B | Blue-based oil-based pigment ink | 理想科学工业株式会社 | 2022-02-18 | — | — | CN | claimed |
| EP-0582699-A1 | PIGMENT COMPOSITION | FRANCOLOR PIGMENTS S.A. (FR) | 1994-02-16 | — | — | EP | claimed |
| US-5256761-A | Polyester coatings containing covalently-bound mesogenic monomers | EASTMAN KODAK COMPANY (US) | 1993-10-26 | — | — | US | claimed |
| WO-1993016137-A1 | PIGMENT COMPOSITION | FRANCOLOR PIGMENTS S.A. (FR) | 1993-08-19 | — | — | WO | claimed |
| EP-0357953-B1 | MIXTURES OF ORGANIC AMMONIUM SALTS AND THEIR USE AS DRAG-REDUCING AGENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-04-07 | — | — | EP | claimed |
| EP-0154223-B1 | PROCESS FOR THE PREPARATION OF 6-ACETOXY-2-NAPHTHOIC ACID AND OF PURE 6-HYDROXY-2-NAPHTHOIC ACID | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-10-19 | — | — | EP | claimed |
| US-4618701-A | Process for preparing 6-acetoxy-2-naphthoic-acid and pure 6-hydroxy-2-naphthoic acid | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-10-21 | — | — | US | claimed |
| US-4600766-A | Process for producing cross-linked resin from bis(2-oxazoline) and aromatic hydroxy-carboxylic acid | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1986-07-15 | — | — | US | claimed |
| EP-0041478-B1 | PROCESS FOR THE CONDITIONING OF AZO PIGMENTS, AND THEIR USE | CIBA-GEIGY AG (CH) | 1983-12-28 | — | — | EP | claimed |
| US-4369038-A | Transfer-printing paper, its manufacture and uses | CIBA-GEIGY LTD. (CH) | 1983-01-18 | — | — | US | claimed |
| US-3961887-A | Process for the printing of cellulose containing textile material | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-06-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250170094-A1 | ANTI-INFLUENZA VIRUS PHARMACEUTICAL FORMULATIONS | HRH1, SLC30A5, AASDHPPT | CDC25B 3029/4885NR4A1 2397/4885NR4A2 3213/4885 |
| US-20250302824-A1 | IN SITU READY-TO-USE INJECTION FORMULATIONS OF POSACONAZOLE FREE OF CYCLODEXTRIN AND ITS DERIVATIVES | CYP3A7, ROR1, CYP3A4 | CDC25B 734/4885NR4A1 663/4885NR4A2 1338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.